APA (7th ed.) Citation

Kuwana, M., & Tomiyama, Y. (2025). Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia. International Journal of Hematology, 121(3), 356-362. https://doi.org/10.1007/s12185-025-03924-2

Chicago Style (17th ed.) Citation

Kuwana, Masataka, and Yoshiaki Tomiyama. "Long-term Safety and Efficacy of Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia." International Journal of Hematology 121, no. 3 (2025): 356-362. https://doi.org/10.1007/s12185-025-03924-2.

MLA (9th ed.) Citation

Kuwana, Masataka, and Yoshiaki Tomiyama. "Long-term Safety and Efficacy of Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia." International Journal of Hematology, vol. 121, no. 3, 2025, pp. 356-362, https://doi.org/10.1007/s12185-025-03924-2.